Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU
This program, part of Horizon Europe, aims to bolster the European health industry by advancing Health Technology Assessment (HTA) methodology and expertise. It focuses on facilitating the uptake of innovative HTA methods developed through EU-funded research and harmonizing HTA practices across the EU and Associated Countries through targeted training programs. The initiative seeks to improve evidence-based decision-making and patient access to novel health technologies.
Who is Funded
This section outlines the general eligibility criteria for funding, detailing who can apply, the geographical scope of the program, and its overarching strategic objectives in the health sector.
What is Funded
This section details the types of projects, thematic areas, and developmental stages that are eligible for funding under this program.
Type and Scope of Funding
This section provides details on the nature of the financial support available, including the type of funding instrument and the specific financial amounts per project.
Conditions and Requirements
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases.
Application Procedure
This section guides potential applicants through the program's application and selection process, including submission requirements and evaluation procedures.
Legal Basis
This section identifies the foundational legal instruments and overarching policies that establish and govern the funding program, ensuring its mandate and operational framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
5,000,000 €
Allocated Budget:
5,000,000 €
Award Channel:
Framework Programme Call
Region:
European Union (EU), Associated Countries, United States of America
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Pharmaceutical Industry
Beneficiaries:
Health Technology Assessment (HTA) bodies, healthcare providers, patients, health systems, health industry, small- and medium-sized enterprises (SMEs)
Application Type:
Optional Consortium
Funding Stages:
Applied Research, Implementation, Capacity Building, Policy Development, Service Delivery
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Website: